Peer-influenced content. Sources you trust. No registration required. This is HCN.

Articles related to MYELOMA

Clinical Oncology News

APHEXDA in Combination with Filgrastim Approved For Patients with Multiple Myeloma

Hematology/Oncology October 2nd 2023

OBR Oncology

BMS Accused by HMO of Patent Fraud to Allegedly Sustain Pomalyst Monopoly

Hematology/Oncology September 11th 2023

Myeloma Research News

Elranatamab, Now Elrexfio, Approved for Hard-to-treat Myeloma

Hematology/Oncology September 5th 2023

The New England Journal of Medicine

Mezigdomide plus Dexamethasone in Relapsed and Refractory Multiple Myeloma

Hematology/Oncology September 5th 2023

OBR Oncology

FDA Grants Accelerated Approval to Elranatamab for Relapsed or Refractory Multiple Myeloma

Hematology/Oncology August 21st 2023

Roswell Park

Roswell Park Study is First to Show That Exercise Strengthens Immune System in Multiple Myeloma Patients

Hematology/Oncology August 14th 2023

The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form